Reaction
Hepatic Artery Thrombosis reporting signals
As of the last recalculation, Hepatic Artery Thrombosis appears in 289 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is TACROLIMUS (PRR 81.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tacrolimus | 110 | 81.0 | 81.1 |
| Valganciclovir | 18 | 73.3 | 73.3 |
| Valganciclovir Hydrochloride | 18 | 73.3 | 73.3 |
| Basiliximab | 11 | 70.0 | 70.1 |
| Tacrolimus Ointment 0.1% | 80 | 63.6 | 63.6 |
| Tacrolimus Extended-Release Capsules | 80 | 63.4 | 63.5 |
| Sirolimus | 11 | 61.1 | 61.1 |
| Valganciclovir Hydrochloride Powder, | 8 | 48.6 | 48.6 |
| Dolutegravir Sodium | 5 | 40.6 | 40.6 |
| Tenofovir Disoproxil Fumarate Tablets | 4 | 33.8 | 33.8 |